The panel is also concerned about the safety of older drugs like ibuprofen and diclofenac, and perhaps Abbott Laboratories ' (nyse: ABT - news - people ) Mobic, which has seen its sales skyrocket as a result of Celebrex's problems.
FORBES: Pfizer Wins